Paper37242536
Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer's Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism.
Samman WA and 5 others. Pharmaceuticals (Basel), 2023. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer's Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism. Papers, record 37242536. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37242536
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer's Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References88
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25031641 | Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer's disease. | Alzheimers Res Ther | 2014 | https://conductscience.org/library/papers/25031641 | PubMed |
| 2 | 18817812 | Aluminium-induced electrophysiological, biochemical and cognitive modifications in the hippocampus of aging rats. | Neurotoxicology | 2008 | https://conductscience.org/library/papers/18817812 | PubMed |
| 3 | 18719601 | AMPK: a key regulator of energy balance in the single cell and the whole organism. | Int J Obes (Lond) | 2008 | https://conductscience.org/library/papers/18719601 | PubMed |
| 4 | 22033831 | Therapeutic approaches to age-associated neurocognitive disorders. | Dialogues Clin Neurosci | 2001 | https://conductscience.org/library/papers/22033831 | PubMed |
| 5 | 24200922 | Tissue-type plasminogen activator mediates neuroglial coupling in the central nervous system. | Neuroscience | 2014 | https://conductscience.org/library/papers/24200922 | PubMed |
| 6 | 24664866 | Oxidative stress in Alzheimer's disease. | Neurosci Bull | 2014 | https://conductscience.org/library/papers/24664866 | PubMed |
| 7 | 25153942 | Interactions between amyloid-β and Tau fragments promote aberrant aggregates: implications for amyloid toxicity. | J Phys Chem B | 2014 | https://conductscience.org/library/papers/25153942 | PubMed |
| 8 | 37079191 | Ferulic Acid Improves Synaptic Plasticity and Cognitive Impairments by Alleviating the PP2B/DARPP-32/PP1 Axis-Mediated STEP Increase and Aβ Burden in Alzheimer's Disease. | Neurotherapeutics | 2023 | https://conductscience.org/library/papers/37079191 | PubMed |
| 9 | 8994059 | Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. | J Neurosci | 1997 | https://conductscience.org/library/papers/8994059 | PubMed |
| 10 | 1789684 | Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. | Ann Neurol | 1991 | https://conductscience.org/library/papers/1789684 | PubMed |
| 11 | 24321755 | Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia. | J Neurol Sci | 2014 | https://conductscience.org/library/papers/24321755 | PubMed |
| 12 | 1673214 | Increased muscarinic receptor messenger RNA in Alzheimer's disease temporal cortex demonstrated by in situ hybridization histochemistry. | Brain Res Mol Brain Res | 1991 | https://conductscience.org/library/papers/1673214 | PubMed |
| 13 | 21541279 | Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect. | PLoS One | 2011 | https://conductscience.org/library/papers/21541279 | PubMed |
| 14 | 2303807 | Cholinotoxic effects of aluminum in rat brain. | J Neurochem | 1990 | https://conductscience.org/library/papers/2303807 | PubMed |
| 15 | 11589914 | Acetylcholinesterase in Alzheimer's disease. | Mech Ageing Dev | 2001 | https://conductscience.org/library/papers/11589914 | PubMed |
| 16 | 23224641 | Mitoprotective effect of Centella asiatica against aluminum-induced neurotoxicity in rats: possible relevance to its anti-oxidant and anti-apoptosis mechanism. | Neurol Sci | 2013 | https://conductscience.org/library/papers/23224641 | PubMed |
| 17 | 30391466 | Alogliptin abates memory injuries of hepatic encephalopathy induced by acute paracetamol intoxication via switching-off autophagy-related apoptosis. | Life Sci | 2018 | https://conductscience.org/library/papers/30391466 | PubMed |
| 18 | 22015471 | Elevation of glutathione as a therapeutic strategy in Alzheimer disease. | Biochim Biophys Acta | 2012 | https://conductscience.org/library/papers/22015471 | PubMed |
| 19 | 1730616 | Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. | J Biol Chem | 1992 | https://conductscience.org/library/papers/1730616 | PubMed |
| 20 | 30181696 | The combination of canagliflozin and omega-3 fatty acid ameliorates insulin resistance and cardiac biomarkers via modulation of inflammatory cytokines in type 2 diabetic rats. | Korean J Physiol Pharmacol | 2018 | https://conductscience.org/library/papers/30181696 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42548880 | Dapagliflozin and cognitive impairment: pharmacological mechanisms, translational evidence, and future directions. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42548880 | PubMed |
| 42418535 | Effect of Cosmos Caudatus supplementation and aerobic exercise on selected neurobehaviour, biochemical profile and histology in rats with mild cognitive impairment (MCI) induced by AlCl3: Study Protocol. | PLoS One | 2026 | https://conductscience.org/library/papers/42418535 | PubMed |
| 42334656 | Dapagliflozin pretreatment attenuates focal cerebral ischemia-reperfusion injury in rats. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42334656 | PubMed |
| 42117829 | Behavioral Paradigms and Methodological Variability in Aluminum Chloride-Induced Rat Models of Alzheimer's Disease: A Structured Review. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42117829 | PubMed |
| 41998450 | Dapagliflozin ameliorates motor deficits in a Parkinson's disease model induced by 6-OHDA: An integrative in vivo and in silico approach from α-synuclein/A2AAR/TH/TNF-α to APAF-1/caspase-3 modulation. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/41998450 | PubMed |
| 41879449 | Mechanisms and Research Progress of SGLT-2 Inhibitors in Diabetes Mellitus-Related Cognitive Impairment. | Curr Diabetes Rev | 2026 | https://conductscience.org/library/papers/41879449 | PubMed |
| 41751214 | Mechanistic Links Between the Gut Microbiome and Longevity Therapeutics. | Biomedicines | 2026 | https://conductscience.org/library/papers/41751214 | PubMed |
| 41599763 | Neuroprotective Potential of SGLT2 Inhibitors in Animal Models of Alzheimer's Disease and Type 2 Diabetes Mellitus: A Systematic Review. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41599763 | PubMed |
| 41020314 | Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management. | Med Res Rev | 2026 | https://conductscience.org/library/papers/41020314 | PubMed |
| 41010553 | Beyond the Cardio-Renal-Metabolic Axis: Emerging Therapeutic Targets and Novel Mechanisms of Action of Flozins. | J Clin Med | 2025 | https://conductscience.org/library/papers/41010553 | PubMed |
| 40325262 | Empagliflozin and memantine combination ameliorates cognitive impairment in scopolamine + heavy metal mixture-induced Alzheimer's disease in rats: role of AMPK/mTOR, BDNF, BACE-1, neuroinflammation, and oxidative stress. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/40325262 | PubMed |
| 39752040 | Drugs repurposing in the experimental models of Alzheimer's disease. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/39752040 | PubMed |
| 39329027 | Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review. | Innov Clin Neurosci | 2024 | https://conductscience.org/library/papers/39329027 | PubMed |
| 38948473 | Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38948473 | PubMed |
| 38766828 | Effects of Cycloastragenol on Alzheimer's Disease in Rats by Reducing Oxidative Stress, Inflammation, and Apoptosis. | Curr Alzheimer Res | 2024 | https://conductscience.org/library/papers/38766828 | PubMed |
| 38455639 | Moringa oleifera leaves ethanolic extract counteracts cortical neurodegeneration induced by aluminum chloride in rats. | Toxicol Res (Camb) | 2024 | https://conductscience.org/library/papers/38455639 | PubMed |
| 38057817 | Ethanol extract of Andrographis paniculata alleviates aluminum-induced neurotoxicity and cognitive impairment through regulating the p62-keap1-Nrf2 pathway. | BMC Complement Med Ther | 2023 | https://conductscience.org/library/papers/38057817 | PubMed |
| 38004485 | Preclinical Studies of Canagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, and Donepezil Combined Therapy in Alzheimer's Disease. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/38004485 | PubMed |
| 37711056 | Dapagliflozin alleviates renal podocyte pyroptosis via regulation of the HO‑1/NLRP3 axis. | Mol Med Rep | 2023 | https://conductscience.org/library/papers/37711056 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACHE | 43 | PubTator's text mining | https://conductscience.org/library/genes/43 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| BACE1 | 23621 | PubTator's text mining | https://conductscience.org/library/genes/23621 | NCBI Gene |
| GSK3B | 2932 | PubTator's text mining | https://conductscience.org/library/genes/2932 | NCBI Gene |
| HMOX1 | 3162 | PubTator's text mining | https://conductscience.org/library/genes/3162 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
| POTEF | 728378 | PubTator's text mining | https://conductscience.org/library/genes/728378 | NCBI Gene |
| PRKAB1 | 5564 | PubTator's text mining | https://conductscience.org/library/genes/5564 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37242536
GET https://conductscience.org/api/papers/v1/37242536/references?page=2